Remus Pharmaceuticals Schedules H1 FY27 Earnings Conference Call
Remus Pharmaceuticals Ltd 路 Intimation 路 29 Oct 2026, 12:39 am
Remus Pharmaceuticals Schedules H1 FY27 Earnings Conference Call Remus Pharmaceuticals Limited will host an earnings conference call on 4th Nov'26 at 12:00 PM IST to discuss its unaudited standalone and consolidated financial results for the half year ended 30th Sep'26 (H1 FY27). The management will be represented by Managing Director Arpit Shah and Chief Financial Officer Bhavik Shah. Universal dial-in access numbers include +91 22 6280 1341 and +91 22 7115 8242, with international toll-free options available. The call recording and transcript will subsequently be made available on the company's website.
Original exchange filing (PDF)
More announcements from Remus Pharmaceuticals Ltd
- Remus Pharmaceuticals Limited has informed the Exchange about Transcript 路 06 Nov 2026
- Remus Pharmaceuticals Limited has informed the Exchange about Audio Recording 路 04 Nov 2026
- Remus Pharmaceuticals Limited has informed the Exchange about Investor Presentation 路 04 Nov 2026
- Remus Pharmaceuticals Limited has informed the Exchange regarding a media release dated November 03, 2026 路 03 Nov 2026
- Remus Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Interim Dividend is 07-Nov-2026. 路 03 Nov 2026
- Remus Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on November 03, 2026, declared Interim Dividend of Rs. 1.00 per equity share. 路 03 Nov 2026
- Remus Pharmaceuticals Limited has submitted to the Exchange Outcome of Board Meeting held on November 03, 2026 路 03 Nov 2026
- Remus Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 03-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Dividend/Other business. 路 03 Nov 2026
